FDA Advisers Concerned About COVID Vaccine Manufacturing, Capacity

Coronavirus vaccine makers are developing vaccines for new variants, but HHS officials and FDA’s vaccine advisers are concerned about the time and manufacturing capacity needed for new vaccines and whether there will be enough demand for manufacturers to continue investing in vaccine development. FDA biologics center Director Peter Marks believes there will be plenty of demand for vaccines, especially considering vaccine immunity wanes over time and a good chunk of the U.S. population still needs to get boosted. Still, there...